Allogeneic versus autologous hematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: A real-world multicenter analysis in ChinaYuewen Wang, Dai‐Hong Liu, Weiping Liu et al.|Cancer Letters|2025Cited by 14
Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients after allo-HSCT: A phase I trial.Xiaoyu Zhu, Liming Yang, Haicun Xie et al.|Journal of Clinical Oncology|2025Cited by 1